CRISPR Market

CRISPR Market Overview

The CRISPR market size is projected to grow from USD 2.87 billion in 2025 to USD 12.22 billion by 2035, representing a CAGR of 15.60% during the forecast period till 2035.

To learn more about this report, request a free sample copy

The new research study consists of CRISPR market and trends analysis, detailed market forecast analysis, and provide actionable strategic recommendations.

CRISPR, an acronym for clustered regularly interspaced short palindromic repeats, is a powerful gene-editing technology that allows scientists to modify DNA with high precision. This is based on the system that was found in bacteria and archaea in 1987. However, it appeared as a breakthrough for biotechnology when in 2012 researchers discovered CRISPR is an immune system that uses Cas9 enzyme to cut DNA at specific locations. At the forefront of this revolution is genetic modification, which has proven to be a game-changer in various sectors, particularly in biomedical research and drug discovery.

The versatility of CRISPR enzymes allows researchers to edit genes with unprecedented precision, paving the way for innovative solutions and making CRISPR a groundbreaking tool of the future for treating genetic disorders, such as cancer and sickle cell disease. Driven by this, the CRISPR gene editing therapies market is witnessing ever-growing growth due to continuous technological advancement and soaring demand for gene and cell therapies. In this connection, the technology is redefining disease modeling by enabling scientists to create accurate models that mimic human diseases. This advancement not only enhances researcher’s understanding of complex conditions but also accelerates the development of targeted therapies. Besides CRISPR applications in biomedical and therapeutics, where it helps in correcting mutations responsible for various diseases and developing CRISPR-based immunotherapies for targeting cancer-causing genes, agriculture application is also reinforcing the growth of the market by enabling crop improvement and livestock engineering.

As a consequence, from established biotech giants to emerging startups, all are eager to harness the potential of CRISPR technology for the research and development of gene editing solutions. With such robust activity and innovation, stakeholders are investing heavily in order to capitalize on opportunities within the burgeoning CRISPR market. For instance, in September 2024, Pairwise secured USD 40 million in Series C funding to advance gene editing in plant breeding. This funding was led by Deerfield Management and other returning investors along with new investor Corteva. Overall, the future of CRISPR is promising however, regulatory uncertainties and complexity in off-target effects and delivery are key challenges that are essential to address to maximize the CRISPR technology potential.

CRISPR Market Share Insights

The CRISPR Market report presents an in-depth analysis of the various companies that are involved in offering CRISPR, across different segments, as defined in the table below:

CRISPR Market: Report Attributes / Market Segmentations

CRISPR Market Segmentation

Market Share by Type of Product & Service

The global CRISPR market is characterized by various products & services wherein products sub-segment exhibit dominance and is expected to capture the highest (~51%) of the market share by 2035. Among products, CRISPR kits and regents accelerate the segment’s growth due to their importance in research and development. These kits and regents are fundamentally for all CRISPR-based experiments making them indispensable for academic research pharmaceutical R&D and biotech companies. Furthermore, the service segment is expected to rise at a faster (18.84%) growth rate in the upcoming years owing to increasing research and development and expanding CRISPR applications.

Market Share by Type of Technology

On the basis of type of technology, CRISPR-Cas9 has been leading the segment and is anticipated to hold (~49%) of the market share till the forecast period. Being the first and most well-known CRISPR system, CRIPR-Cas9 is the most widely adopted technology. It is considered the backbone of most gene-editing applications, thereby lifting the CRISPR-Cas9 market development. While CRISPR-Cas12 technology is emerging speedily and is likely to grow at a faster CAGR of (17.92%) during this projection period. This can be accredited to its ability to target single-stranded DNA and its use in diagnostics.

Market Share by Type of Application

The market for CRISPR is distributed into multiple applications such as agriculture, drug discovery & development, and others. As per the gene editing market research, the biomedical research application is projected to occupy the largest (~47%) share by 2035. Biomedical research widely utilizes CRISPR technology for basic and applied research in genomic, disease modeling, drug discovery, and functional genomics. It has become a powerful tool for studying complex biological processes, thus, fortifying market demand. Apart from this, the drug discovery & development segment is gaining traction in the industry and is expected to grow at a higher (19.52%) growth rate during this projection timeframe driven by its advantages in precision in gene editing, high throughput screening, and enhanced drug efficacy and safety.

Market Share by Type of End User

On the basis of the type of end-user, academic and research institutions are fostering segment dominance with (~48%) of the current market share. Academic and research institutions were among the first to adopt CRISPR technology driving its initial development and widespread use. Also, the high volume of research and access to funding and grants from government agencies to support CRISPR-related projects contribute to continuing to lead the segment. Moreover, the pharmaceutical and biotechnology companies are predicted to register an excellent (19.66%) growth rate in the upcoming decade. This growth can be ascribed to the growing drug discovery initiatives, target validation, and therapeutic development.

Market Share by Geographical Regions

This segment highlights the distribution of the CRISPR Market across various geographical regions, such as North America, Europe, Asia, Latin America, the Middle East and North Africa, and the rest of the world. According to our projection, the CRISPR technology market is expected to be dominated by North America which will likely capture the maximum (~47%) of the market share till the forecast period.

Apart from this, the market for CRISPR is reaching new heights of expansion in Asia and is projected to experience a noteworthy (20.41%) CAGR during this forecast period. Several factors are contributing to this exceeding growth such as the growing biotechnology sector and government initiatives to promote gene editing and biotechnology. Additionally, there is a rising demand for healthcare solutions, including CRISPR-based therapies for genetic disorders, cancer, and infectious diseases. Asian researchers are companies making significant contributions to CRISPR technology. For instance, South Korea’s ToolGen is a pioneer in CRISPR-cas9 applications. Driven by these factors, the CRISPR-Cas9 market shows promising growth and will continue to rise throughout this projection period.

CRISPR Market Key Insights

The “CRISPR Market, Till-2035: Industry Trends and Global Forecasts” report features an extensive study of the current market landscape, market size and future opportunities within the CRISPR market, during the given forecast period. The market report highlights the efforts of several stakeholders involved in this rapidly emerging segment of the service providers industry. Key takeaways of the CRISPR market report are briefly discussed below.

Key Drivers of the CRISPR Market

The CRISPR market is expanding exponentially and is likely to continue to rise driven by bourgeoning demand for gene and cell therapies. CRISPR technology has huge therapeutic potential and is widely being used to develop treatments for genetic disorders, cancer, infectious diseases, and rare diseases. It is also aiding in the development of personalized medicine and regenerative medicine tailored to individual genetic profiles and tissue engineering. Furthermore, increasing investment and funding from government and private venture capitals is solidifying the innovation and commercialization of the technology, thus, magnifying the market prospects. Moreover, ongoing technological advancements in next-generation gene editing tools, precision, and efficiency along with the integration of AI and ML are creating lucrative opportunities to the evolution of the industry in the upcoming decade.

CRISPR Market Competitive Landscape

Currently, several biotech firms, startups, and pharmaceutical companies are changing the competitive landscape dynamically. Key players including CRISPR Therapeutics, Thermo Fisher Scientific, Merc KGaA, and others are dominating the market through their CRISPR-based gene therapies and diverse product offerings. These companies are constantly endeavoring to secure substantial CRISPR based gene therapies market share by focusing on collaboration and partnership. Additionally, these companies are aligning with emerging trends, such as next-generation CRISPR systems and AI & machine learning integration which help them global expansion.

Market Challenges in CRISPR Market

CRISPR market is one of the promising industries and witnessing ample growth, however, some notable challenges, such as regulatory hurdles and technical challenges can confine the growth rate of the market. The industry is multifaceted and has unclear regulatory pathways as frameworks for CRISPR-based therapies and products are still evolving, leading to uncertainty for companies. This is also due to the fact that different countries have varying regulations for CRISPR applications, which create complications for global commercialization. Additionally, complexity in genome editing, delivery efficiency, and off-target effects can be considerable bottlenecks for the expansion of the market.

Regional Analysis: North America is Expected to Dominate the Market with the Largest CRISPR Market Share

North America is leading the trajectory of innovation in the CRISPR gene editing market and is anticipated to dominate the industry with (~47%) of the market share by 2035. This dominance is attributed to the region’s strong research and development infrastructure and significant support from the government through funding for CRISPR related research as well as growing venture capital and private investment are also driving the market growth by investing in CRISPR startups and biotechnology companies. Additionally, high healthcare expenditure, advanced regulatory framework, and rising demand for precision medicines are elevating the growth of genetic engineering in the region. Moreover, leading companies based in North America are reinforcing their market dominance through their robust collaboration between pharmaceutical companies academia and biotech firms to push CRISPR innovation and commercialization forward in the region. For instance,

Leading CRISP Companies

Examples of key players involved in the market for CRISPR (which have also been captured in this market report, arranged in alphabetical order) include Agilent Technologies (US), Applied StemCell (US), Caribou Bioscience (US), CRISPR Therapeutics (Switzerland), Danaher (US), eGenesis (US), GeneCopoeia (US), Genscript Biotech (US), Inscripta (US), Lonza Group (Switzerland), Mammoth Bioscience (US), Merck KGaA (Germany), New England Biolabs (US), Precision BioScience (US), Synthego (US), Thermo Fisher Scientific (US), ToolGen (South Korea), Twist Bioscience (US). This market report includes an easily searchable excel database of all the companies who have adopted the CRISPR market.

Recent Developments in CRISPR Market

• In August 2024, CRISPR QC, a leading biotech company introduced innovative products under the CRISPR Analytics Platforms to enhance gene editing. These tools offer precise insights into CRISPR workflows, helping researchers optimize their experiments with greater accuracy.
• In March 2024, Carolina Biological Supply Company partnered with Gene Editing Institute to manufacture and distribute cost-effective CRISPR Box Kits for high school science labs.
• In January 2024, Danaher collaborated with Innovative Genomes Institute (IGI) to develop CRISPR-based gene therapies to potentially cure rare diseases by creating a scalable technology for the iterative development of gene therapies.

CRISPR Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain, across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report CRISPR market, 2020-2024 (Historical Trends) and till-2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the CRISPR market providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall CRISPR market including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view on the current state of the CRISPR market their likely evolution in the mid-long term.
• A detailed assessment of the CRISPR market landscape, based on several relevant parameters, including year of experience, company size, location of headquarters, and ownership structure.
• Elaborate profiles of prominent players engaged in the CRISPR market, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, CRISPR market portfolio, moat analysis, recent developments, and an informed future outlook.
• A qualitative assessment of the various megatrends ongoing in the CRISPR industry, including rising innovation of next-generation CRISPR and expansion into therapeutics.
• An analysis highlighting the key unmet needs across the CRISPR market, featuring insights generated from real-time data on unmet needs as identified from social media posts, recent publications, industry blogs and the views of key opinion leaders expressed on online platforms.
• An in-depth analysis of various patents that have been filed / granted related to CRISPR market and its components, based on various parameters, such as type of patent, patent publication year, patent age and leading players.
• A detailed analysis of recent developments in the CRISPR market domain, based on relevant parameters such as year of initiative, type of initiative (partnerships and collaborations, expansions, funding and product launches), geographical distribution and most active players (in terms of number of recent developments).
• Key winning strategies framework that helps in analyzing the level of competition within an industry, by tracing the key market activities including partnership, funding, expansion of leading players
• A qualitative analysis, highlighting the five competitive forces prevalent in CRISPR market, including threats for new entrants, bargaining power of suppliers, bargaining power of customers, threats of substitution and rivalry among existing competitors.
• A discussion on affiliated global CRISPR market trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall CRISPR market.
• A value chain analysis featuring a discussion on various stakeholders involved in the development of the CRISPR market, from suppliers to end-users.
• A detailed estimate of the current market size and the future growth potential of the CRISPR market over the next decade. Based on multiple parameters we have provided an informed estimate on the market evolution during the forecast period 2025-2035. The report also features the likely distribution of the current and forecasted opportunity within the CRISPR market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future market across various types of products & services such as kits & enzyme, libraries, cell line engineering, gRNA design & vector construction, and screening services.
• Detailed projections of the current and future market across various types of technology such as CRISPR-Cas9, CRISPR-Cas12, CRISPR-13, and others.
• Detailed projections of the current and future market across various types of applications such as agriculture, biomedical research, drug discovery & development, and others.
• Detailed projections of the current and future market across various types of end users such as academic & research institutes, pharmaceutical & biotechnology companies, and others.
• Detailed projections of the current and future CRISPR market across various geographical regions, such as North America (US, Canada, Mexico and other North American countries), Europe (Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Norway, Russia, Spain, Sweden, Switzerland, UK and other European countries), Asia (China, India, Japan, Singapore, South Korea and other Asian countries), Middle East and North Africa (Egypt, Iran, Iraq, Israel, Kuwait, Saudi Arabia, UAE and other MENA countries), Latin America (Brazil, Chile, Colombia, Venezuela and other Latin American countries) and rest of the world (Australia, New Zealand and other countries).

Author: Ronit Sharma and Neha Kashyap